↓ Skip to main content

The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlle…

Overview of attention for article published in BMJ Open, October 2013
Altmetric Badge

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The effect of a glucagon-like peptide-1 receptor agonist on glucose tolerance in women with previous gestational diabetes mellitus: protocol for an investigator-initiated, randomised, placebo-controlled, double-blinded, parallel intervention trial
Published in
BMJ Open, October 2013
DOI 10.1136/bmjopen-2013-003834
Pubmed ID
Authors

Signe Foghsgaard, Louise Vedtofte, Elisabeth R Mathiesen, Jens A Svare, Lise L Gluud, Jens J Holst, Peter Damm, Filip K Knop, Tina Vilsbøll

Abstract

Pregnancy is associated with decreased insulin sensitivity, which is usually overcome by a compensatory increase in insulin secretion. Some pregnant women are not able to increase their insulin secretion sufficiently, and consequently develop gestational diabetes mellitus (GDM). The disease normally disappears after delivery. Nevertheless, women with previous GDM have a high risk of developing type 2 diabetes (T2D) later in life. We aim to investigate the early development of T2D in women with previous GDM and to evaluate whether treatment with the glucagon-like peptide-1 receptor (GLP-1R) agonist, liraglutide, may modify their risk of developing T2D.

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Unknown 49 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 13 26%
Student > Bachelor 9 18%
Researcher 6 12%
Student > Ph. D. Student 5 10%
Other 4 8%
Other 12 24%
Unknown 1 2%
Readers by discipline Count As %
Medicine and Dentistry 23 46%
Psychology 4 8%
Nursing and Health Professions 3 6%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Social Sciences 3 6%
Other 7 14%
Unknown 7 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2013.
All research outputs
#2,017,994
of 3,627,775 outputs
Outputs from BMJ Open
#1,489
of 2,125 outputs
Outputs of similar age
#52,923
of 98,184 outputs
Outputs of similar age from BMJ Open
#124
of 176 outputs
Altmetric has tracked 3,627,775 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,125 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,184 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 176 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.